These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14587304)

  • 21. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) and treatment of chronic renal disease.
    Buggy D; Breathnach A; Keogh B; Cooke T; Feely J
    J Intern Med; 1993 Nov; 234(5):453-5. PubMed ID: 8228788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of pituitary-thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis.
    Ross RJ; Goodwin FJ; Houghton BJ; Boucher BJ
    Ann Clin Biochem; 1985 Mar; 22 ( Pt 2)():156-60. PubMed ID: 3923894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.
    Anwar N; Bhatnagar D; Short CD; Mackness MI; Durrington PN; Prais H; Gokal R
    Nephrol Dial Transplant; 1993; 8(1):71-4. PubMed ID: 8381941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of C-reactive protein levels in peritoneal dialysis patients.
    Fine A
    Kidney Int; 2002 Feb; 61(2):615-20. PubMed ID: 11849404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
    Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
    Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel inflammatory marker in dialysis patients: YKL-40.
    Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
    Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure.
    Al-Saady NM; Leatham EW; Gupta S; Kwan JT; Eastwood JB; Seymour CA
    Heart; 1999 Feb; 81(2):134-40. PubMed ID: 9922347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
    Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
    Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and adequacy of continuous ambulatory peritoneal dialysis.
    Wu G; Kim D; Oreopoulos DG
    Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S48-61. PubMed ID: 3909582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
    McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
    Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting low values of serum albumin in CAPD patients.
    Han DS; Lee SW; Kang SW; Choi KH; Lee HY; Cho EY; Lee JH
    Adv Perit Dial; 1996; 12():288-92. PubMed ID: 8865921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.